In a recent study published in the journal JACC Advances, researchers in the United States examined the presence of coronary atherosclerosis using coronary computed tomography angiography (CCTA) in ...
The “dose-response” relationships that apolipoprotein B (apoB) and LDL cholesterol have with coronary artery disease, all-cause mortality, and cardiovascular mortality do not appear to have lower ...
In another study of dyslipidemic patients not treated with hypolipidemic drugs (baseline examination), a very good correlation between LDL-C and apoB (r = 0.903; p < 0.001) was found. [66] In spite of ...
More accurate prediction of heart disease: A new study found that a blood test that specifically looks at lipoproteins associated with “bad cholesterol” could be a more accurate predictor of heart ...
ApoB is emerging as a crucial piece of the heart health puzzle, even as sophisticated machines whir and beep with promises of precise diagnoses in the gleaming corridors of modern medicine. As ...
Use of a clinical trials screening tool in the NCI Community Oncology Research Program (NCORP) to enhance accrual and promote disparities research. This is an ASCO Meeting Abstract from the 2019 ASCO ...
Elevated levels of high-density lipoprotein (HDL) and apolipoprotein A1 (apoA1) are associated with a reduced risk for amyotrophic lateral sclerosis (ALS), new research shows. The study also linked a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback